<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35750046</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-6711</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Stem cell reports</Title><ISOAbbreviation>Stem Cell Reports</ISOAbbreviation></Journal><ArticleTitle>Upregulation of &#x3b2;-catenin due to loss of miR-139 contributes to motor neuron death in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1650</StartPage><EndPage>1665</EndPage><MedlinePgn>1650-1665</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.stemcr.2022.05.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-6711(22)00272-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the loss of motor neurons (MNs). There are no effective treatments and patients usually die within 2-5 years of diagnosis. Emerging commonalities between familial and sporadic cases of this complex multifactorial disorder include disruption to RNA processing and cytoplasmic inclusion bodies containing TDP-43 and/or FUS protein aggregates. Both TDP-43 and FUS have been implicated in RNA processing functions, including microRNA biogenesis, transcription, and splicing. In this study, we explore the misexpression of microRNAs in an iPSC-based disease model of FUS ALS. We identify the downregulation of miR-139, an MN-enriched microRNA, in FUS and sporadic ALS MN. We discover that miR-139 downregulation leads to the activation of canonical WNT signaling and demonstrate that the WNT transcriptional mediator &#x3b2;-catenin is a major driver of MN degeneration in ALS. Our results highlight the importance of homeostatic RNA networks in ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK; Living Systems Institute, University of Exeter, Exeter EX4 4QD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namboori</LastName><ForeName>Seema C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK; Living Systems Institute, University of Exeter, Exeter EX4 4QD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Ammarah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Living Systems Institute, University of Exeter, Exeter EX4 4QD, UK; Biosciences, University of Exeter, Exeter EX4 4QD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaker</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaxman</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Nidhi S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>York Biomedical Research Institute, Hull York Medical School, University of York, York YO10 5DD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henley</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randall</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology and Biotechnologies Charles Darwin, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy; Center for Life Nano- &amp; Neuro-Science, Fondazione Istituto Italiano di Tecnologia (IIT), 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanton</LastName><ForeName>Lawrence W</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhinge</LastName><ForeName>Akshay</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter EX1 2LU, UK; Living Systems Institute, University of Exeter, Exeter EX4 4QD, UK. Electronic address: a.bhinge@exeter.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T033029/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT204909MA</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Stem Cell Reports</MedlineTA><NlmUniqueID>101611300</NlmUniqueID><ISSNLinking>2213-6711</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C555098">MIRN139 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051176">beta Catenin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051176" MajorTopicYN="N">beta Catenin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FUS</Keyword><Keyword MajorTopicYN="N">WNT</Keyword><Keyword MajorTopicYN="N">iPSC</Keyword><Keyword MajorTopicYN="N">miR-139</Keyword><Keyword MajorTopicYN="N">microRNA</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">sporadic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35750046</ArticleId><ArticleId IdType="pmc">PMC9287677</ArticleId><ArticleId IdType="doi">10.1016/j.stemcr.2022.05.019</ArticleId><ArticleId IdType="pii">S2213-6711(22)00272-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agarwal V., Bell G.W., Nam J.-W., Bartel D.P. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. doi: 10.7554/elife.05005.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.05005</ArticleId><ArticleId IdType="pmc">PMC4532895</ArticleId><ArticleId IdType="pubmed">26267216</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin N.D., Bai G., Klug J.R., Bonanomi D., Pankratz M.T., Gifford W.D., Hinckley C.A., Sternfeld M.J., Driscoll S.P., Dominguez B., et al. Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. Science. 2015;350:1525&#x2013;1529. doi: 10.1126/science.aad2509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad2509</ArticleId><ArticleId IdType="pmc">PMC4913787</ArticleId><ArticleId IdType="pubmed">26680198</ArticleId></ArticleIdList></Reference><Reference><Citation>Anton R., Chatterjee S.S., Simundza J., Cowin P., Dasgupta R. A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS One. 2011;6:e26257. doi: 10.1371/journal.pone.0026257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026257</ArticleId><ArticleId IdType="pmc">PMC3197157</ArticleId><ArticleId IdType="pubmed">22043311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bafico A., Liu G., Goldin L., Harris V., Aaronson S.A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6:497&#x2013;506. doi: 10.1016/j.ccr.2004.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2004.09.032</ArticleId><ArticleId IdType="pubmed">15542433</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A., Namboori S.C., Zhang X., VanDongen A.M.J., Stanton L.W. Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis. Stem Cell Rep. 2017;8:856&#x2013;869. doi: 10.1016/j.stemcr.2017.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic lateral sclerosis. N.&#xa0;Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/nejmra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550&#x2013;553. doi: 10.1126/science.1068999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1068999</ArticleId><ArticleId IdType="pubmed">11910072</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryja V., &#x10c;ervenka I., &#x10c;aj&#xe1;nek L., &#x10c;aj&#xe1;nek L. The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? Crit. Rev. Biochem. Mol. Biol. 2017;52:614&#x2013;637. doi: 10.1080/10409238.2017.1350135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2017.1350135</ArticleId><ArticleId IdType="pmc">PMC6047740</ArticleId><ArticleId IdType="pubmed">28741966</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA dysregulation in amyotrophic lateral sclerosis. Front. Genet. 2018;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;ervenka I., Wolf J., Ma&#x161;ek J., Krejci P., Wilcox W.R., Kozub&#xed;k A., Schulte G., Gutkind J.S., Bryja V. Mitogen-activated protein kinases promote WNT/&#x3b2;-Catenin signaling via phosphorylation of LRP6. Mol. Cell Biol. 2011;31:179&#x2013;189. doi: 10.1128/mcb.00550-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.00550-10</ArticleId><ArticleId IdType="pmc">PMC3019858</ArticleId><ArticleId IdType="pubmed">20974802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Y., Liu H., Wu X., Yu L., Wang S., Zhao C., Du H., Wang X. Activation of the Wnt/&#x3b2;-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem. Biophys. Res. Commun. 2012;420:397&#x2013;403. doi: 10.1016/j.bbrc.2012.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2012.03.006</ArticleId><ArticleId IdType="pubmed">22426476</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Guan Y., Zhang Z., Liu H., Wang S., Yu L., Wu X., Wang X. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol. Res. 2012;34:390&#x2013;399. doi: 10.1179/1743132812y.0000000027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1743132812y.0000000027</ArticleId><ArticleId IdType="pubmed">22643084</ArticleId></ArticleIdList></Reference><Reference><Citation>Clevers H. Wnt/&#x3b2;-Catenin signaling in development and disease. Cell. 2006;127:469&#x2013;480. doi: 10.1016/j.cell.2006.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.10.018</ArticleId><ArticleId IdType="pubmed">17081971</ArticleId></ArticleIdList></Reference><Reference><Citation>Damalas A., Ben-Ze&#x2019;ev A., Simcha I., Shtutman M., Leal J.F., Zhurinsky J., Geiger B., Oren M. Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 1999;18:3054&#x2013;3063. doi: 10.1093/emboj/18.11.3054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.11.3054</ArticleId><ArticleId IdType="pmc">PMC1171387</ArticleId><ArticleId IdType="pubmed">10357817</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Zhai H., Bigio E.H., Yan J., Fecto F., Ajroud K., Mishra M., Ajroud-Driss S., Heller S., Sufit R., et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010;67:739&#x2013;748. doi: 10.1002/ana.22051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22051</ArticleId><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R., Santini L., Colantoni A., Peruzzi G., de Turris V., Alfano V., Bozzoni I., Rosa A. FUS mutant human motoneurons display altered transcriptome and microRNA pathways with implications for ALS pathogenesis. Stem Cell Rep. 2017;9:1450&#x2013;1462. doi: 10.1016/j.stemcr.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.004</ArticleId><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens B.M., Yan J., Miller N., Deng H.-X., Siddique T., Ma Y.C. A novel ALS-associated variant in UBQLN4 regulates motor axon morphogenesis. Elife. 2017;6:e25453. doi: 10.7554/elife.25453.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.25453</ArticleId><ArticleId IdType="pmc">PMC5451210</ArticleId><ArticleId IdType="pubmed">28463112</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A., Eitan C., Liou L.-L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A., et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Lunn J.S., Paez-Colasante X., Bender D.E., Yung R., Sakowski S.A., Feldman E.L. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms. Mol. Cell. Neurosci. 2016;71:34&#x2013;45. doi: 10.1016/j.mcn.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.12.008</ArticleId><ArticleId IdType="pmc">PMC4761498</ArticleId><ArticleId IdType="pubmed">26704906</ArticleId></ArticleIdList></Reference><Reference><Citation>Frade J.M., Ovejero-Benito M.C. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle. 2015;14:712&#x2013;720. doi: 10.1080/15384101.2015.1004937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2015.1004937</ArticleId><ArticleId IdType="pmc">PMC4418291</ArticleId><ArticleId IdType="pubmed">25590687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaidatzis D., Burger L., Florescu M., Stadler M.B. Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation. Nat. Biotechnol. 2015;33:722&#x2013;729. doi: 10.1038/nbt.3269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3269</ArticleId><ArticleId IdType="pubmed">26098447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs K.L., Kalmar B., Rhymes E.R., Fellows A.D., Ahmed M., Whiting P., Davies C.H., Greensmith L., Schiavo G. Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. 2018;9:596. doi: 10.1038/s41419-018-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pmc">PMC5964181</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId></ArticleIdList></Reference><Reference><Citation>Godin J.D., Poizat G., Hickey M.A., Maschat F., Humbert S. Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington&#x2019;s disease. EMBO J. 2010;29:2433&#x2013;2445. doi: 10.1038/emboj.2010.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.117</ArticleId><ArticleId IdType="pmc">PMC2910267</ArticleId><ArticleId IdType="pubmed">20531388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Fern&#xe1;ndez C., Gonzalez P., Andres-Benito P., Ferrer I., Rodr&#xed;guez F.J. Wnt signaling alterations in the human spinal cord of amyotrophic lateral sclerosis cases: spotlight on Fz2 and Wnt5a. Mol. Neurobiol. 2019;56:6777&#x2013;6791. doi: 10.1007/s12035-019-1547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1547-9</ArticleId><ArticleId IdType="pubmed">30924074</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu W., Li X., Wang J. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Oncol. Rep. 2014;31:397&#x2013;404. doi: 10.3892/or.2013.2831.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2013.2831</ArticleId><ArticleId IdType="pubmed">24190507</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509&#x2013;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S.P., Gambin Y., Gomez G.A., Verma S., Giles N., Michael M., Wu S.K., Guo Z., Johnston W., Sierecki E., et al. Cortactin scaffolds Arp2/3 and WAVE2 at the epithelial zonula adherens. J.&#xa0;Biol. Chem. 2014;289:7764&#x2013;7775. doi: 10.1074/jbc.m113.544478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m113.544478</ArticleId><ArticleId IdType="pmc">PMC3953287</ArticleId><ArticleId IdType="pubmed">24469447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J., Imhof S., Wainger B.J. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol. Dis. 2020;134:104680. doi: 10.1016/j.nbd.2019.104680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinske L.C., Dos Santos F.R.C., Ohara D.T., Ohno-Machado L., Kreth S., Galante P.A.F. MiRIAD update: using alternative polyadenylation, protein interaction network analysis and additional species to enhance exploration of the role of intragenic miRNAs and their host genes. Database. 2017;2017:bax053. doi: 10.1093/database/bax053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/bax053</ArticleId><ArticleId IdType="pmc">PMC5569676</ArticleId><ArticleId IdType="pubmed">29220447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor J.H., Soh E.S.-Y., Tan L.Y., Lim V.J.W., Santosa M.M., Winanto, Ho B.X., Fan Y., Soh B.-S., Ng S.-Y. Cell cycle&#xa0;inhibitors protect motor neurons in an organoid model of Spinal Muscular Atrophy. Cell Death Dis. 2018;9:1100. doi: 10.1038/s41419-018-1081-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1081-0</ArticleId><ArticleId IdType="pmc">PMC6204135</ArticleId><ArticleId IdType="pubmed">30368521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K., Ishigaki S., Iguchi Y., Kawai K., Fujioka Y., Yokoi S., Abdelhamid R.F., Nagano S., Mochizuki H., Katsuno M., Sobue G. Characteristic features of FUS inclusions in spinal&#xa0;motor neurons of sporadic amyotrophic lateral sclerosis. J.&#xa0;Neuropathol. Exp. Neurol. 2020;79:370&#x2013;377. doi: 10.1093/jnen/nlaa003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlaa003</ArticleId><ArticleId IdType="pubmed">32142134</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal M.K. Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M., Chen G. High Ca2+-phosphate transfection efficiency in low-density neuronal cultures. Nat. Protoc. 2006;1:695&#x2013;700. doi: 10.1038/nprot.2006.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.86</ArticleId><ArticleId IdType="pubmed">17406298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA. 2012;109:3347&#x2013;3352. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., Haussler D. The human genome browser at UCSC. Genome Res. 2002;12:996&#x2013;1006. doi: 10.1101/gr.229102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.229102</ArticleId><ArticleId IdType="pmc">PMC186604</ArticleId><ArticleId IdType="pubmed">12045153</ArticleId></ArticleIdList></Reference><Reference><Citation>Korobeynikov V.A., Lyashchenko A.K., Blanco-Redondo B., Jafar-Nejad P., Shneider N.A. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat. Med. 2022;28:104&#x2013;116. doi: 10.1038/s41591-021-01615-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01615-z</ArticleId><ArticleId IdType="pmc">PMC8799464</ArticleId><ArticleId IdType="pubmed">35075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurita H., Yabe S., Ueda T., Inden M., Kakita A., Hozumi I. MicroRNA-5572 is a novel MicroRNA-regulating SLC30A3 in sporadic amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2020;21:4482. doi: 10.3390/ijms21124482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124482</ArticleId><ArticleId IdType="pmc">PMC7350020</ArticleId><ArticleId IdType="pubmed">32599739</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A., Subramanian A., Pinchback R., Thorvaldsd&#xf3;ttir H., Tamayo P., Mesirov J.P. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739&#x2013;1740. doi: 10.1093/bioinformatics/btr260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr260</ArticleId><ArticleId IdType="pmc">PMC3106198</ArticleId><ArticleId IdType="pubmed">21546393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Long H., Sun B., Cheng L., Zhao S., Zhu Y., Zhao R., Zhu J. miR-139-5p represses BMSC osteogenesis via targeting wnt/&#x3b2;-catenin signaling pathway. DNA Cell Biol. 2017;36:715&#x2013;724. doi: 10.1089/dna.2017.3657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2017.3657</ArticleId><ArticleId IdType="pubmed">28622009</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J., et al. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS. Nat. Commun. 2018;9:2010. doi: 10.1038/s41467-018-04373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04373-8</ArticleId><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M., Dini Modigliani S., Torrelli G., Rosa A., Di Carlo V., Caffarelli E., Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 2012;31:4502&#x2013;4510. doi: 10.1038/emboj.2012.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.319</ArticleId><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>Purro S.A., Galli S., Salinas P.C. Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases. J.&#xa0;Mol. Cell Biol. 2014;6:75&#x2013;80. doi: 10.1093/jmcb/mjt049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjt049</ArticleId><ArticleId IdType="pmc">PMC4344549</ArticleId><ArticleId IdType="pubmed">24449494</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu B., Han X., Tang Y., Shen N. A novel vector-based method for exclusive overexpression of star-form microRNAs. PLoS One. 2012;7:e41504. doi: 10.1371/journal.pone.0041504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041504</ArticleId><ArticleId IdType="pmc">PMC3400617</ArticleId><ArticleId IdType="pubmed">22829954</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I., et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Bowser R. p53 and cell cycle proteins participate in spinal motor neuron cell death in ALS&#x223c;!2010-02-16&#x223c;!2010-02-19&#x223c;!2010-04-14&#x223c;! Open Pathol. J. 2010;4:11&#x2013;22. doi: 10.2174/1874375701004010011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874375701004010011</ArticleId><ArticleId IdType="pmc">PMC3092395</ArticleId><ArticleId IdType="pubmed">21572928</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenstein I., Eitan C., Diaz-Garcia S., Haim G., Magen I., Siany A., Hoye M.L., Rivkin N., Olender T., Toth B., et al. Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology. Sci. Transl. Med. 2019;11:eaav5264. doi: 10.1126/scitranslmed.aav5264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aav5264</ArticleId><ArticleId IdType="pmc">PMC7057809</ArticleId><ArticleId IdType="pubmed">31852800</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas-Prats E., Martinez-Gonzalez L., Gonzalo-Consuegra C., Liachko N.F., Perez C., Ram&#xed;rez D., Kraemer B.C., Martin-Requero &#xc1;., Perez D.I., Gil C., et al. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: a new therapeutic approach for amyotrophic lateral sclerosis. Eur. J. Med. Chem. 2021;210:112968. doi: 10.1016/j.ejmech.2020.112968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112968</ArticleId><ArticleId IdType="pubmed">33139113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu Y.K., Collins S.E., Ho H.-Y.H., Zhao H., Kuruvilla R. An autocrine Wnt5a-Ror signaling loop mediates sympathetic target innervation. Dev. Biol. 2013;377:79&#x2013;89. doi: 10.1016/j.ydbio.2013.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2013.02.013</ArticleId><ArticleId IdType="pmc">PMC3774606</ArticleId><ArticleId IdType="pubmed">23454479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sama R.R.K., Fallini C., Gatto R., McKeon J.E., Song Y., Rotunno M.S., Penaranda S., Abdurakhmanov I., Landers J.E., Morfini G., et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci. Rep. 2017;7:115. doi: 10.1038/s41598-017-00091-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00091-1</ArticleId><ArticleId IdType="pmc">PMC5428330</ArticleId><ArticleId IdType="pubmed">28273913</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlange T., Matsuda Y., Lienhard S., Huber A., Hynes N.E. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 2007;9:R63. doi: 10.1186/bcr1769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/bcr1769</ArticleId><ArticleId IdType="pmc">PMC2242658</ArticleId><ArticleId IdType="pubmed">17897439</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz J.C., Ebmeier C.C., Podell E.R., Heimiller J., Taatjes D.J., Cech T.R. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev. 2012;26:2690&#x2013;2695. doi: 10.1101/gad.204602.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.204602.112</ArticleId><ArticleId IdType="pmc">PMC3533074</ArticleId><ArticleId IdType="pubmed">23249733</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellers K.J., Elliott C., Jackson J., Ghosh A., Ribe E., Rojo A.I., Jarosz-Griffiths H.H., Watson I.A., Xia W., Semenov M., et al. Amyloid &#x3b2; synaptotoxicity is Wnt-PCP dependent and blocked by fasudil. Alzheimers Dement. 2018;14:306&#x2013;317. doi: 10.1016/j.jalz.2017.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.09.008</ArticleId><ArticleId IdType="pmc">PMC5869054</ArticleId><ArticleId IdType="pubmed">29055813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sticht C., De La Torre C., Parveen A., Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13:e0206239. doi: 10.1371/journal.pone.0206239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206239</ArticleId><ArticleId IdType="pmc">PMC6193719</ArticleId><ArticleId IdType="pubmed">30335862</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tank E.M., Figueroa-Romero C., Hinder L.M., Bedi K., Archbold H.C., Li X., Weskamp K., Safren N., Paez-Colasante X., Pacut C., et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat. Commun. 2018;9:2845. doi: 10.1038/s41467-018-05049-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05049-z</ArticleId><ArticleId IdType="pmc">PMC6054632</ArticleId><ArticleId IdType="pubmed">30030424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung Y.-T., Peng K.-C., Chen Y.-C., Yen Y.-P., Chang M., Thams S., Chen J.-A. Mir-17&#x223c;92 confers motor neuron subtype differential resistance to ALS-associated degeneration. Cell Stem Cell. 2019;25:193&#x2013;209.e7. doi: 10.1016/j.stem.2019.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.04.016</ArticleId><ArticleId IdType="pubmed">31155482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y., Gao X., Li G., Fu H., Cui D., Liu H., Jin W., Zhang Y. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res. 2013;73:6046&#x2013;6055. doi: 10.1158/0008-5472.can-13-0358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.can-13-0358</ArticleId><ArticleId IdType="pubmed">23950210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Huang C., Reddy Chintagari N., Bhaskaran M., Weng T., Guo Y., Xiao X., Liu L. miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/&#x3b2;-catenin pathway. Nucleic Acids Res. 2013;41:3833&#x2013;3844. doi: 10.1093/nar/gks1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1460</ArticleId><ArticleId IdType="pmc">PMC3616718</ArticleId><ArticleId IdType="pubmed">23396279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wexler E.M., Paucer A., Kornblum H.I., Palmer T.D., Geschwind D.H. Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cell. 2009;27:1130&#x2013;1141. doi: 10.1002/stem.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.36</ArticleId><ArticleId IdType="pmc">PMC2782960</ArticleId><ArticleId IdType="pubmed">19418460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart T.M., Mutsaers C.A., Riessland M., Reimer M.M., Hunter G., Hannam M.L., Eaton S.L., Fuller H.R., Roche S.L., Somers E., et al. Dysregulation of ubiquitin homeostasis and &#x3b2;-catenin signaling promote spinal muscular atrophy. J.&#xa0;Clin. Invest. 2014;124:1821&#x2013;1834. doi: 10.1172/jci71318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci71318</ArticleId><ArticleId IdType="pmc">PMC3973095</ArticleId><ArticleId IdType="pubmed">24590288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong N., Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43:D146&#x2013;D152. doi: 10.1093/nar/gku1104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1104</ArticleId><ArticleId IdType="pmc">PMC4383922</ArticleId><ArticleId IdType="pubmed">25378301</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Liu T., Liu L., Yao X., Chen L., Fan D., Zhan S., Wang S. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J.&#xa0;Neurol. 2020;267:944&#x2013;953. doi: 10.1007/s00415-019-09652-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L., Guan Y., Wu X., Chen Y., Liu Z., Du H., Wang X. Wnt Signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem. Res. 2013;38:1904&#x2013;1913. doi: 10.1007/s11064-013-1096-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1096-y</ArticleId><ArticleId IdType="pmc">PMC4170800</ArticleId><ArticleId IdType="pubmed">23784673</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Wu Y.-C., Mullane P., Ji Y.J., Liu H., He L., Arora A., Hwang H.-Y., Alessi A.F., Niaki A.G., et al. FUS regulates activity of MicroRNA-mediated gene silencing. Mol. Cell. 2018;69:787&#x2013;801.e8. doi: 10.1016/j.molcel.2018.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.001</ArticleId><ArticleId IdType="pmc">PMC5836505</ArticleId><ArticleId IdType="pubmed">29499134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Chen Y., Yang N., Chen Q., Bao Z., Liu M., Hu S., Li J., Wu X. miR-218-5p regulates skin and hair follicle development through Wnt/&#x3b2;-catenin signaling pathway by targeting SFRP2. J.&#xa0;Cell. Physiol. 2019;234:20329&#x2013;20341. doi: 10.1002/jcp.28633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28633</ArticleId><ArticleId IdType="pubmed">30953362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou F., Mao R., Yang L., Lin S., Lei K., Zheng Y., Ding Y., Zhang P., Cai G., Liang X., Liu J. Targeted deletion of miR-139-5p activates MAPK, NF-&#x3ba;B and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J. 2016;283:1438&#x2013;1452. doi: 10.1111/febs.13678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13678</ArticleId><ArticleId IdType="pubmed">26859226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>